Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey

AstraZeneca1,018 enrolled

Overview

A registry study to identify the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

Study Type

OBSERVATIONAL

Enrollment

1,018

Conditions

Bipolar Disorder

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients previously or currently diagnosed with bipolar disorder * Patients (or any of their relatives) who give a written informed consent. Exclusion Criteria: * Patients who were previously included in this study.

Locations (19)

Research Site

Adana, Turkey (Türkiye)

Research Site

Afyonkarahisar, Turkey (Türkiye)

Research Site

Ankara, Turkey (Türkiye)

Outcomes

Primary Outcomes

Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

Secondary Outcomes

Evaluation of the time period that elapsed since the diagnosis of bipolar disorder

Evaluation of co-morbid psychiatric diseases

Identification of treatment modalities selected according to the disease phase

Identification of the number of first degree relatives diagnosed with bipolar disorder

Evaluation of the relationship between patient and disease characteristics

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.